KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.5379
+0.0306 (6.03%)
At close: Sep 8, 2026, 4:00 PM EDT
0.5355
+0.0282 (5.56%)
Pre-market: Sep 9, 2026, 6:08 AM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $10.4 million as of September 8, 2026. Its market cap has decreased by -89.82% in one year.
Market Cap
10.40M
Enterprise Value
3.17M
1-Year Change
-89.82%
Ranking
Category
Stock Price
$0.54
ChartMarket Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $10.40M, a decrease of -97.58%. That is a compound annual growth rate of -33.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 10.40M | 126.15% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 10.94M |
| Azitra | 10.88M |
| GT Biopharma | 10.87M |
| Lunai Bioworks | 10.84M |
| Vistagen Therapeutics | 10.77M |
| Senti Biosciences Holdings | 10.36M |
| CytoMed Therapeutics | 10.19M |
| Aprea Therapeutics | 10.00M |